Clinical Trials Directory

Trials / Completed

CompletedNCT06873438

The Effect of Probiotics on the Improvement of Intestinal and Immune Function

A Study on the Safety and Effectiveness of Lactobacillus Delbrueckii Subsp. Bulgaricus LB42 in Improving Intestinal and Immune Functions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Wecare Probiotics Co., Ltd. · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Evaluate the effectiveness and safety of Lactobacillus delbrueckii subsp. bulgaricus LB42 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic groupThe experimental phase of this study will last 8 weeks and each subject will receive 3 follow-up visits (week 0, week 4, week 8).
DIETARY_SUPPLEMENTPlacebo groupThe experimental phase of this study will last 8 weeks and each subject will receive 3 follow-up visits (week 0, week 4, week 8).

Timeline

Start date
2025-03-01
Primary completion
2025-05-25
Completion
2025-08-15
First posted
2025-03-12
Last updated
2025-10-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06873438. Inclusion in this directory is not an endorsement.

The Effect of Probiotics on the Improvement of Intestinal and Immune Function (NCT06873438) · Clinical Trials Directory